Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuSil is a specialty materials company focused on ultra-high-purity silicone and related advanced materials used in healthcare, life sciences, and high-technology applications. The business is best known for medical-grade silicones used in implantable devices, drug-delivery systems, diagnostics, and other regulated healthcare products, as well as high-performance materials for aerospace, defense, and electronics. NuSil was founded as an independent company and later merged into Avantor in 2016, where it continues to operate as the NuSil brand within Avantor's portfolio. Its offerings include off-the-shelf and custom silicone formulations, along with technical support, analytical capabilities, and manufacturing for highly regulated end markets. For a biotech or medtech analyst, NuSil is primarily a commercial biomaterials and enabling-technology supplier rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuSil.